Cargando…
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
The aim of this study was to investigate whether the enumeration of circulating tumor cells (CTCs) in blood can differentiate between true localized and metastatic prostate cancer. A cross-sectional study of 104 prostate cancer patients with newly diagnosed high-risk prostate cancer was conducted. I...
Autores principales: | Cieślikowski, Wojciech A., Budna-Tukan, Joanna, Świerczewska, Monika, Ida, Agnieszka, Hrab, Michał, Jankowiak, Agnieszka, Mazel, Martine, Nowicki, Michał, Milecki, Piotr, Pantel, Klaus, Alix-Panabières, Catherine, Zabel, Maciej, Antczak, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017349/ https://www.ncbi.nlm.nih.gov/pubmed/31936460 http://dx.doi.org/10.3390/cancers12010160 |
Ejemplares similares
-
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2023) -
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
por: Budna-Tukan, Joanna, et al.
Publicado: (2019) -
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
por: Cieślikowski, Wojciech A., et al.
Publicado: (2021) -
Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring
por: Kamińska, Paula, et al.
Publicado: (2021) -
Reasons behind the Delayed Diagnosis of Testicular Cancer: A Retrospective Analysis
por: Cieślikowski, Wojciech A., et al.
Publicado: (2023)